英文名稱 |
中文名稱 |
CAS號 |
操作 |
Chenodeoxycholic Acid Impurity 1; Allochenodeoxycholic acid |
鵝去氧膽酸雜質(zhì)1;別鵝去氧膽酸 |
15357-34-3 |
詳細(xì)
|
Obeticholic Acid Impurity 41 |
奧貝膽酸雜質(zhì)41 |
1537866-49-1 |
詳細(xì)
|
Salbutamol Impurity 111 |
沙丁胺醇雜質(zhì)111 |
152880-92-7 |
詳細(xì)
|
Pregabalin Impurity 142 |
普瑞巴林雜質(zhì)142 |
1568110-05-3 |
詳細(xì)
|
Adrenaline Impurity 47 |
腎上腺素雜質(zhì)47 |
1528622-09-4 |
詳細(xì)
|
Pregabalin Impurity 189 |
普瑞巴林雜質(zhì)189 |
156048-92-9 |
詳細(xì)
|
2-(carboxymethyl)oxirane-2,3-dicarboxylic acid |
2-(羧甲基)環(huán)氧乙烷-2,3-二羧酸 |
155551-03-4 |
詳細(xì)
|
Cyclosporin Impurity 31 |
環(huán)孢菌素雜質(zhì)31 |
15375-48-1 |
詳細(xì)
|
Bexarotene Impurity 5 |
貝沙羅汀雜質(zhì)5 |
153559-48-9 |
詳細(xì)
|
Montelukast Impurity 35 |
孟魯司特雜質(zhì)35 |
152922-86-6 |
詳細(xì)
|
Fexofenadine EP Impurity D(Fexofenadine Methyl Ester) |
非索非那定EP雜質(zhì)D(非索非那定甲酯) |
154825-96-4 |
詳細(xì)
|
Perampanel Impurity 35 |
吡侖帕奈雜質(zhì)35 |
152846-62-3 |
詳細(xì)
|
Trazodone hydrochloride Impurity 31 |
鹽酸曲唑酮雜質(zhì)31 |
157072-18-9 |
詳細(xì)
|
2-oxo-3-phenylpropanoic acid |
2-氧代-3-苯基丙酸 |
156-06-9 |
詳細(xì)
|
1-chloro-1-methoxyethane |
1-氯-1-甲氧基乙烷 |
1538-87-0 |
詳細(xì)
|
Ritonavir Impurity 49 |
利托那韋雜質(zhì)49 |
156732-13-7 |
詳細(xì)
|
Piboserod |
哌波色羅 |
152811-62-6 |
詳細(xì)
|
Valganciclovir Impurity 23 |
纈更昔洛韋雜質(zhì)23 |
156061-08-4 |
詳細(xì)
|
Iopromide EP Impurity A |
碘普羅胺EP雜質(zhì)A |
154361-51-0 |
詳細(xì)
|
Cyclopropanesulfonamide |
環(huán)丙烷磺酰胺 |
154350-29-5 |
詳細(xì)
|
Fulvestrant Impurity 63 |
氟維司群雜質(zhì)63 |
153004-31-0 |
詳細(xì)
|
Biapenem Impurity 11 |
比阿培南雜質(zhì)11 |
155835-09-9 |
詳細(xì)
|
Saxagliptin Impurity 38 |
沙格列汀雜質(zhì)38 |
1564266-73-4 |
詳細(xì)
|
Luliconazole Impurity L |
盧立康唑雜質(zhì)L |
1579886-24-0 |
詳細(xì)
|
Bempedoic acid Impurity 21 |
貝派地酸雜質(zhì)21 |
1529323-27-0 |
詳細(xì)
|
(R)-4-(2-(benzylamino)-1-hydroxyethyl)benzene-1,2-diol |
(R) -4-(2-(芐胺基)-1-羥乙基)苯-1,2-二醇 |
1544695-73-9 |
詳細(xì)
|
Sorafenib Impurity 21 |
索拉非尼雜質(zhì)21 |
1535-76-8 |
詳細(xì)
|
StaupriMide |
硫磺酰亞胺 |
154589-96-5 |
詳細(xì)
|
Ponatinib D8 |
帕納替尼D8 |
1562993-37-6 |
詳細(xì)
|
1-Methoxypiperazine |
1-甲氧基哌嗪 |
157517-72-1 |
詳細(xì)
|
Valsartan Impurity 120 |
纈沙坦雜質(zhì)120 |
153959-55-8 |
詳細(xì)
|
Lifitegrast Impurity 52 |
立他司特雜質(zhì)52 |
157942-12-6 |
詳細(xì)
|
Butylphthalide Impurity 43 |
丁苯酞雜質(zhì)43 |
152567-80-1 |
詳細(xì)
|
2-phenylpropane-1,3-diol |
2-苯基丙烷-1,3-二醇 |
1570-95-2 |
詳細(xì)
|
Bexarotene Impurity 6 |
貝沙羅汀雜質(zhì)6 |
153559-45-6 |
詳細(xì)
|
Brinzolamide Impurity 16 |
布林佐胺雜質(zhì)16 |
154127-41-0 |
詳細(xì)
|
Exemestane Impurity 7 |
依西美坦雜質(zhì)7 |
152764-26-6 |
詳細(xì)
|
(+)-Cloprostenol Isopropyl Ester |
(+)-氯前列烯醇異丙酯 |
157283-66-4 |
詳細(xì)
|
Mianserin Hydrochloride EP Impurity D |
鹽酸米安色林EP雜質(zhì)D |
157994-98-4 |
詳細(xì)
|
Metacresol Impurity 21 |
間甲酚雜質(zhì)21 |
15359-97-4 |
詳細(xì)
|
Eribulin mesylate Impurity 4 |
甲磺酸艾日布林雜質(zhì)4 |
1534341-95-1 |
詳細(xì)
|
3-Chlorobenzeneacetonitrile |
3-氯苯乙腈 |
1529-41-5 |
詳細(xì)
|
Cytarabine Impurity 49; Azacitidine Impurity 22 |
阿糖胞苷雜質(zhì)49;阿扎胞苷雜質(zhì)22 |
154568-81-7 |
詳細(xì)
|
5-chloro-2-cyano-5-oxopentan-2-yl benzodithioate |
5-氯-2-氰基-5-氧代戊烷-2-基苯二硫代甲酸酯 |
1537911-32-2 |
詳細(xì)
|
Ticagrelor Impurity 228 |
替卡格雷雜質(zhì)228 |
155855-51-9 |
詳細(xì)
|
Topiroxostat Impurity 61 |
托匹司他雜質(zhì)61 |
1549944-68-4 |
詳細(xì)
|
Fluvastatin Impurity 13 |
氟伐他汀雜質(zhì)13 |
155229-76-8 |
詳細(xì)
|
Ropivacaine Impurity 64 |
羅哌卡因雜質(zhì)64 |
1543937-58-1 |
詳細(xì)
|
Vitamin E Impurity 82 |
維生素E雜質(zhì)82 |
1560716-42-8 |
詳細(xì)
|
Fluocinolone acetonide EP Impurity F |
醋酸氟輕松EP雜質(zhì)F |
1526-01-8 |
詳細(xì)
|
(4,5-dihydrofuran-2-yl)methanamine |
(4,5-二氫呋喃-2-基)甲胺 |
1554159-53-3 |
詳細(xì)
|
Docetaxel Impurity 72 |
多西他賽雜質(zhì)72 |
155396-69-3 |
詳細(xì)
|
Bisphenol AP |
雙酚AP |
1571-75-1 |
詳細(xì)
|
Thioguanine |
硫鳥嘌呤 |
154-42-7 |
詳細(xì)
|
Bexarotene |
貝沙羅汀 |
153559-49-0 |
詳細(xì)
|
(R)-1-(1-([1,1'-biphenyl]-4-yl)-3-chloropropan-2-yl)pyrrolidine-2,5-dione |
(R) -1-(1-([1,1'-聯(lián)苯]-4-基)-3-氯丙-2-基)吡咯烷-2,5-二酮 |
1573000-36-8 |
詳細(xì)
|
Miglitol Impurity C |
米格列醇雜質(zhì)C |
1550201-56-3 |
詳細(xì)
|
Efavirenz Enantiomer |
依法韋倫對映體 |
154801-74-8 |
詳細(xì)
|
PaliperidoneImpurityA |
帕利哌酮雜質(zhì)A |
1569268-43-4 |
詳細(xì)
|
Bispyribac |
釓布醇雜質(zhì)139 |
156970-79-5 |
詳細(xì)
|
Bupropion Impurity 28 |
安非他酮雜質(zhì)28 |
153365-82-3 |
詳細(xì)
|
(S)-1-([1,1'-biphenyl]-4-yl)-3-chloropropan-2-ol |
(S) -1-([1,1'-聯(lián)苯]-4-基)-3-氯丙-2-醇 |
1573000-28-8 |
詳細(xì)
|
Zinc protoporphyrin |
鋅原卟啉 |
15442-64-5 |
詳細(xì)
|
Rifaximin EP Impurity D; Rifaximin Y |
利福霉素Y |
15271-73-5 |
詳細(xì)
|
CHX-A''-DTPA |
CHX-A''-DTPA(B-355) |
157380-45-5 |
詳細(xì)
|
Acetylcysteine Impurity 32 |
乙酰半胱氨酸雜質(zhì)32 |
152612-69-6 |
詳細(xì)
|
Posaconazole Impurity 247 |
泊沙康唑雜質(zhì)247 |
156570-10-4 |
詳細(xì)
|
Dapagliflozin Impurity 98 |
達(dá)格列凈雜質(zhì)98 |
1573-17-7 |
詳細(xì)
|
4-methyl-4-(pyridin-2-yldisulfaneyl)pentanoic acid |
4-甲基-4-(吡啶-2-基二硫?;┪焖?/td>
| 1537891-69-2 |
詳細(xì)
|
Fluometuron |
美羅培南雜質(zhì)5 |
154634-04-5 |
詳細(xì)
|
Octreotide EP Impurity C |
奧曲肽EP雜質(zhì)C |
1546983-16-7 |
詳細(xì)
|
Minoxidil Impurity 28 |
米諾地爾雜質(zhì)28 |
156-81-0 |
詳細(xì)
|
Deoxycholic Acid Impurity 8 |
脫氧膽酸雜質(zhì)8 |
15375-18-5 |
詳細(xì)
|
Triricinolein Impurity 5 |
三蓖麻精雜質(zhì)5 |
15505-14-3 |
詳細(xì)
|
Mupirocin Impurity 22(Ribofuranose) |
莫匹羅星雜質(zhì)22(呋喃核糖) |
15761-67-8 |
詳細(xì)
|
Arbidol Impurity 38 |
阿比朵爾雜質(zhì)38 |
153633-14-8 |
詳細(xì)
|
Paclitaxel Impurity 28 |
紫杉醇雜質(zhì)28 |
153415-46-4 |
詳細(xì)
|
Nimodipine Impurity 33 |
尼莫地平雜質(zhì)33 |
155861-24-8 |
詳細(xì)
|
Fluralaner Impurity 36 |
氟雷拉納雜質(zhì)36 |
1564638-18-1 |
詳細(xì)
|
Mizolastine Impurity 8 |
咪唑斯汀雜質(zhì)8 |
1569097-23-9 |
詳細(xì)
|
Ertugliflozin Impurity 4 |
埃格列凈雜質(zhì)4 |
1528739-05-0 |
詳細(xì)
|
S-((1-(cyanomethyl)cyclopropyl)methyl) ethanethioate |
S-(1-(氰甲基)環(huán)丙基)甲基)乙硫酯 |
152922-72-0 |
詳細(xì)
|
Carfilzomib Impurity C |
卡非佐米雜質(zhì)C |
1528769-13-2 |
詳細(xì)
|
Metformin Impurity 46; Nafamostat Impurity B |
二甲雙胍雜質(zhì)46;萘莫司他雜質(zhì)B |
15639-51-7 |
詳細(xì)
|
Tofacitinib Impurity 53 |
托法替尼雜質(zhì)53 |
1527525-58-1 |
詳細(xì)
|
Ticagrelor Impurity 240 (Tranylcypromine) |
替卡格雷雜質(zhì)240 |
155-09-9 |
詳細(xì)
|
Valsartan Impurity 126 |
纈沙坦雜質(zhì)126 |
157366-46-6 |
詳細(xì)
|
Dapagliflozin Impurity 144 |
達(dá)格列凈雜質(zhì)67 |
1528636-07-8 |
詳細(xì)
|
4-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine |
4-甲基-6,7-二氫-5H-吡咯并[2,3-d]嘧啶 |
1541399-43-2 |
詳細(xì)
|
Camphor Impurity 15 |
樟腦雜質(zhì)15 |
154335-57-6 |
詳細(xì)
|
Palbociclib Impurity 117 |
帕博西尼雜質(zhì)117 |
153473-24-6 |
詳細(xì)
|
Abemaciclib Impurity 2 |
阿貝西利雜質(zhì)2 |
156732-12-6 |
詳細(xì)
|
2-isopropyl-1,3-dioxepane |
2-異丙基-1,3-二氧雜環(huán)丙烷 |
15351-37-8 |
詳細(xì)
|
Epalrestat Impurity 27 |
依帕司他雜質(zhì)27 |
15289-56-2 |
詳細(xì)
|
Travoprost Impurity 30 |
曲伏前列素雜質(zhì)30 |
152521-02-3 |
詳細(xì)
|
Latanoprost Impurity 14 |
拉坦前列素雜質(zhì)14 |
1563176-58-8 |
詳細(xì)
|
Lansoprazole Impurity 45 |
蘭索拉唑雜質(zhì)45 |
1551185-85-3 |
詳細(xì)
|
Epinastine Impurity 21 |
依匹斯汀雜質(zhì)21 |
1557-50-2 |
詳細(xì)
|
Baricitinib-d5 |
巴瑞克替尼-d5 |
1564241-79-7 |
詳細(xì)
|
Levetiracetam Impurity 29 |
左乙拉西坦雜質(zhì)29 |
1543353-92-9 |
詳細(xì)
|